Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does inflammation lower circulating zinc?

Inflammation can rapidly lower circulating zinc through hepatic redistribution rather than a true loss of total-body zinc.

PlausibleOctober 16, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Inflammation lowers circulating zinc by increasing hepatic zinc sequestration through cytokine-driven metallothionein expression.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says inflammatory cytokines can drive zinc into the liver, where metallothionein binding helps retain it and reduce the amount left in circulation. The mechanism framing supports an acute-phase redistribution response, with moderate confidence from experimental and clinical observations. This means a low serum zinc level during inflammation may reflect sequestration as well as nutritional status.

Verified conclusion

Inflammation can produce a rapid fall in circulating zinc through an acute-phase redistribution response rather than necessarily reflecting reduced total-body zinc stores. The proposed liver-centered pathway is supported with moderate confidence, particularly by experimental data.

Clinical and translational evidence

  • Human experimental endotoxemia shows that serum zinc declines rapidly after rises in TNF-α and IL-6, consistent with cytokine-driven zinc redistribution during acute inflammation.
  • In acutely ill older hospital populations, serum zinc was inversely associated with C-reactive protein in two groups (r = −0.33 and −0.29; both P < 0.001). Aged-care residents similarly had lower zinc concentrations alongside inflammatory markers.
  • These associations vary across older populations, with some cohorts showing no zinc–CRP correlation and reports of sex-specific patterns. For a 71-year-old man, a low serum zinc result during illness or elevated CRP therefore warrants interpretation in its inflammatory context rather than being treated automatically as evidence of nutritional zinc deficiency.

Mechanistic evidence

  • IL-6 promotes hepatocyte zinc uptake through induction of ZIP14, a zinc-importing transporter. In mice lacking IL-6, inflammation did not induce hepatic ZIP14 or the characteristic inflammatory hypozincemia.
  • In rat hepatocytes, IL-6 increased metallothionein expression and intracellular zinc. Inflammatory animal models likewise show increased hepatic metallothionein and liver zinc.
  • Metallothionein can bind intracellular zinc, providing a coherent mechanism by which cytokine-stimulated hepatic uptake retains zinc in the liver and lowers the circulating concentration.

Bottom line

  • The claim is scientifically supported: inflammation-associated cytokines, particularly IL-6, can increase hepatic zinc uptake and metallothionein-mediated intracellular binding, contributing to lower circulating zinc. In clinical practice, serum zinc during active inflammation is best viewed as a marker influenced by redistribution as well as nutritional status.

References

  1. Interleukin 6 regulates metallothionein gene expression ... — pmc.ncbi.nlm.nih.gov ↗
  2. Lack of a Role for Induced Zinc Deficiency or Metallothionein ... — academic.oup.com ↗
  3. Acute phase reaction and acute phase proteins - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  4. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response | PNAS — pnas.org ↗
  5. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response — pnas.org ↗
  6. Zinc and Regulation of Inflammatory Cytokines - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  7. An inverse relationship between serum zinc and C-reactive protein levels in acutely ill elderly hospital patients — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible12 sourcesDoes a C-peptide of 8.87 with glucose 197 suggest insulin resistance?→Plausible8 sourcesDoes skeletal muscle account for major glucose disposal and increase uptake during contraction?→